Literature Review On Management Of Atrial Fibrillation And Its Implementation In Rural Areas
Keywords:
atrial fibrillation, management, rural areasAbstract
Atrial fibrillation (AF) is a common and chronic heart condition affecting patients in various healthcare settings, including rural clinics. The purpose of this review is to discuss management of AF and its implementation in rural areas. The review employs traditional literature review methodologies through literature obtained from Google Scholar and PubMed. This literature review considers both retrospective and prospective studies, and includes guidelines from official health organizations. Based on the review, AF management often intersects with other health conditions, thus it can be a marker of stroke risk and an indicator of serious diseases. Rural areas physicians face challenges in implementing accurate diagnostics and adopting new treatments while coordinating with specialists to provide comprehensive care. Well-integrated AF management ultimately aims to simplify the treatment options and improve the quality of patient care, especially in rural areas.
References
Ponamgi SP, Siontis KC, Rushlow DR, Graff-Radford J, Montori V, Noseworthy PA. Screening and management of atrial fibrillation in primary care. BMJ. 2021 Apr 12;373:n379. doi: 10.1136/bmj.n379. PMID: 33846159
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 120:1501–17. doi: 10.1161/CIRCRESAHA.117.309732
Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998 Sep 8;98(10):946-52. doi: 10.1161/01.cir.98.10.946. PMID: 9737513.
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014 Mar 15;383(9921):999-1008. doi: 10.1016/S0140-6736(13)61752-3. Epub 2013 Sep 29. PMID: 24084292; PMCID: PMC4159698.
Passman R. Atrial fibrillation and stroke: The more we learn, the less we understand. Am Heart J. 2018 Jul;201:158-159. doi: 10.1016/j.ahj.2018.04.009. Epub 2018 Apr 18. PMID: 29910049.
Rush, K.L., Burton, L., Van Der Merwe, F. et al. Atrial fibrillation care in rural communities: a mixed methods study of physician and patient perspectives. BMC Fam Pract 20, 144 (2019). https://doi.org/10.1186/s12875-019-1029-1
Lacoste, J.L., Szymanski, T.W., Avalon, J.C. et al. Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies. Am J Cardiovasc Drugs 22, 475–496 (2022). https://doi.org/10.1007/s40256-022-00529-6
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke 2021;16:217-21. doi:10.1177/1747493019897870
Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013;112:1142-7. doi:10.1016/j.amjcard.2013.05.063
Siontis KC, Gersh BJ, Killian JM, et al. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: Characteristics and prognostic implications. Heart Rhythm 2016;13:1418-24. doi:10.1016/j.hrthm.2016.03.003
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration With the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed With the Special Contribution of the European Heart Rhythm Association (EHRA) of. Eur Heart J (2021) 42:373–498. doi: 10.1093/eurheartj/ehaa612
Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Njølstad I, et al. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the Biomarcare Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation (2017)136:1588–97. doi: 10.1161/CIRCULATIONAHA.117.028981
Cheung CC, Nattel S, Macle L, Andrade JG. Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines. Can J Cardiol. 2021 Oct;37(10):1607-1618. doi: 10.1016/j.cjca.2021.06.011. Epub 2021 Jun 26. PMID: 34186113.
Chung MK, Eckhardt LL, Chen LY, et al, American Heart Association Electrocardiography and Arrhythmias Committee and Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Council on Lifestyle and Cardiometabolic Health. Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association. Circulation 2020;141:e750-72. doi:10.1161/ CIR.0000000000000748
Andrade JG. MY APPROACH to Atrial Fibrillation: Rate vs Rhythm Control. Trends Cardiovasc Med. 2017 Apr;27(3):226-227. doi: 10.1016/j.tcm.2016.09.009. Epub 2016 Oct 6. PMID: 28161145.
Pellman J, Sheikh F. Atrial fibrillation: mechanisms, therapeutics, and future directions. Compr Physiol. 2015 Apr;5(2):649-65. doi: 10.1002/cphy.c140047. PMID: 25880508; PMCID: PMC5240842.
Prystowsky EN, Padanilam BJ. Preserve the brain: primary goal in the therapy of atrial fibrillation. J Am Coll Cardiol. 2013 Aug 6;62(6):540-2. doi: 10.1016/j.jacc.2013.04.038. Epub 2013 May 15. PMID: 23684681.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016 Nov;18(11):1609-1678. doi: 10.1093/europace/euw295. Epub 2016 Aug 27. PMID: 27567465.
Chen JY, Zhang AD, Lu HY, Guo J, Wang FF, Li ZC. CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis. J Geriatr Cardiol. 2013 Sep;10(3):258-66. doi: 10.3969/j.issn.1671-5411.2013.03.004. PMID: 24133514; PMCID: PMC3796700.
DeSimone CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, Asirvatham SJ, Holmes DRJr. Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation. J Am Coll Cardiol 2017;70:1173-82. doi:10.1016/j. jacc.2017.07.724
Freedman B, Potpara TS, Lip GY. Stroke prevention in atrial fibrillation. Lancet. 2016;388(10046):806–817. https://doi.org/10.1016/S0140-6736(16)31257-0.
Lip GY. The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol. 2011 Jul 26;8(10):602-6. doi: 10.1038/nrcardio.2011.112. PMID: 21788962.
Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace. 2011;13(3):308–328. https://doi.org/10.1093/europace/eur002
Liu T, Korantzopoulos P, Xu G, Shehata M, Li D, Wang X, Li G. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and atrial fibrillation: a meta-analysis. Europace. 2011 Mar;13(3):346-54. doi: 10.1093/europace/euq407. Epub 2010 Nov 13. PMID: 21076147.
Li J, Gao M, Zhang M, Liu D, Li Z, Du J, Hou Y. Treatment of atrial fibrillation: a comprehensive review and practice guide. Cardiovasc J Afr. 2020 May/Jun 23;31(3):153-158. doi: 10.5830/CVJA-2019-064. Epub 2020 Mar 18. PMID: 32186324; PMCID: PMC8762786.
January CT, Wann LS, Alpert JS. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–76. https://doi.org/10.1161/CIR.0000000000000041
Packer DL, Mark DB, Robb RA, et al, CABANA Investigators. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA 2019;321:1261-74. doi:10.1001/jama.2019.0693.
Chew DS, Black-Maier E, Loring Z, et al. Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies. Circ Arrhythm Electrophysiol 2020;13:e008128. doi:10.1161/ CIRCEP.119.008128.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. Rev Esp Cardiol (Engl Ed) 2017;70:50. doi:10.1016/j.rec.2016.11.033.
